CP-690550 (Tofacitinib) Citrate: Selectivity & Specificity
CP-690550 (Tofacitinib) Citrate is a potent pan-JAK inhibitor targeting all JAK isoforms.
Jump to:
- CP-690550 (Tofacitinib) Citrate Mechanism of Action: JAK3 Inhibition in Lymphocyte Research
- CP-690550 (Tofacitinib) Citrate Working Concentration | Cell Culture | Treatment
- CP-690550 (Tofacitinib) Citrate Solubility in DMSO
- CP-690550 (Tofacitinib) Citrate Combination Database
- CP-690550 (Tofacitinib) Citrate Molecular Weight | Chemical Structure | Stock Solution
- CP-690550 (Tofacitinib) Citrate Sigma (PZ0017)? Try a better option.
- CP-690550 (Tofacitinib) Citrate MedChemExpress (HY-40354A)? Try a better option.
- CP-690550 (Tofacitinib) Citrate Tocris (4556)? Try a better option.
- CP-690550 (Tofacitinib) Citrate Cayman (11598)? Try a better option.
- CP-690550 (Tofacitinib) Citrate Abmole (M3616)? Try a better option.
- CP-690550 (Tofacitinib) Citrate SDS｜MSDS
- CP-690550 (Tofacitinib) Citrate in Rheumatoid Arthritis
- CP-690550 (Tofacitinib) Citrate in Ulcerative Colitis
- CP-690550 (Tofacitinib) Citrate in Alopecia Areata and Autoimmune Dermatoses